Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PharmaEssentia
Pharma
FDA approves label expansion for PharmaEssentia's Besremi
The FDA has signed off on a label expansion for PharmaEssentia's Besremi, endorsing it for the rare bone marrow disorder essential thrombocythemia.
Kevin Dunleavy
Aug 31, 2026 8:25am
PharmaEssentia taps Incyte alum as it eyes Besremi expansion
May 28, 2026 8:08am
PharmaEssentia to build $46M manufacturing plant in Puerto Rico
Feb 10, 2026 1:30pm
PharmaEssentia plots expansion for blood cancer med Besremi
Jan 7, 2025 9:00am
PharmaEssentia nabs MorphoSys alum for CCO role
Dec 6, 2024 9:48am
PharmaEssentia shares rare blood cancer stories in video series
Sep 19, 2023 9:45am